Head of Investor Relations
Axsome Therapeutics, Inc. (AXSM)Equibles does not estimate personal net worth.
Get an email with a short summary when Axsome Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get AXSM alertsAshley Dongdress is recorded as Head of Investor Relations at Axsome Therapeutics, Inc. (AXSM). Ashley Dongdress has spoken on 4 earnings calls across 1 company, most recently for Axsome Therapeutics, Inc. on November 2, 2026. Axsome Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Axsome Therapeutics, Inc. includes Herriot Tabuteau (CEO), Nick Pizzie (CFO), Mark Jacobson (COO) and 4 others.
“Joining me today are Dr. Ario Tabuto, Chief Executive Officer, Nick Pizzi, Chief Financial Officer, and Ari Mazel, Chief Commercial Officer, who will begin with prepared remarks.”
“Good morning, everyone, and welcome to AXM's second quarter 2026 earnings conference call. Joining me today to discuss our results for the quarter are Dr. Ario Tabuto, Chief Executive Officer, Nick Pizzi, Chief Financial Officer, and Nari Maisel, Chief Commercial Officer, who will begin our call with prepared remarks.”
“Good morning, and thank you for joining AXM's first quarter 2026 earnings conference call. With us today are Dr. Ario Tabuto, our chief executive officer, Nick Pizzi, our chief financial officer, and Ari Maybel, our chief commercial officer, who will begin our call with prepared remarks.”
“Good morning, and thank you all for joining ACCENT's fourth quarter and full year 2025 earnings conference call. With us today are Dr. Ario Tabuto, our Chief Executive Officer, Nick Pizzi, our Chief Financial Officer, and Ari Mazel, our Chief Commercial Officer, who will begin our call with prepared remarks.”
Biotechnology · Healthcare
Head of Investor Relations
